Kitazato Corporation logo

Kitazato Corporation

368A.T

JPXHealthcareMedical - Instruments & Supplies

Latest quote

¥1,506

−¥36.00 · -2.33%

Aug 24, 1:19 PM JST

368A.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Kitazato Corporation is a Japanese entity primarily focused on the research, development, production, and distribution of specialized medical devices and related supplies used in fertility treatment. Headquartered in Shizuoka, Japan, the company offers a comprehensive suite of products catering to reproductive medicine, including precision needles, catheters, and cannulas. Their offerings also extend to advanced vitrification media and equipment, sperm processing media and tools, in-vitro fertilization (IVF) culture media, microsurgical instruments, and various essential labware products. Founded in 1998, the firm was formerly known as Kitazato Biopharma Co., Ltd. Kitazato Corporation operates as a subsidiary under Kitasato Shoji Co., Ltd.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
JP
CEO
Futoshi Inoue
Listed since
Jun 25, 2025
Employees
83

Market position

Day range

Current ¥1,506

52-week range

Current ¥1,506

Open
¥1,550
Previous close
¥1,542
Volume
45.2K
0.3× average
Average volume
151.96K
Average daily volume
Market cap
60.24B JPY
Beta
0.21
Market reference 1
50-day average
¥1,369.1
+10.00% above average
200-day average
¥1,406.87
+7.05% above average

Earnings

Latest EPS result
0.15

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates29.0919.449.790.13Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q3 2025, reported Aug 8, 2025: actual 18.64, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual 26.48, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 6, 2026: actual 25.31, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 30, 2026: actual 26.95, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Jul 31, 2026: actual 0.155, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates3.31B2.21B1.11B15.77MQ3 '25No estimateQ4 '25No estimateQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q3 2025, reported Aug 8, 2025: actual 2.43B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual 2.81B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 6, 2026: actual 2.69B JPY, estimate 2.47B JPY, surprise +9.01%, Beat. Q2 2026, reported Apr 30, 2026: actual 3.01B JPY, estimate 3.07B JPY, surprise -1.82%, Miss. Q3 2026, reported Jul 31, 2026: actual 18.55M JPY, estimate 2.6B JPY, surprise -99.29%, Miss. Q4 2026, reported Nov 12, 2026: actual —, estimate 2.88B JPY, surprise —, Comparison unavailable.

ETFs holding 368A.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 368A.T

research.disclaimer